A snapshot on an industry in its infancy:
As of 2018 Canada is busily taking the position as the world leading hub for development of cannabinol derived from marijuana plants for both medicinal and recreational purposes. In the half decade leading up to 2018 close to 200 companies have been licensed by health Canada, while a number of companies have gone public, all of these with greatly inflated stock values in a very optimistic and opportunistic marketplace; there is a new gold rush in Canada! On the flip side - behind the curtain of optimism, reality is that none of the currently listed companies in Canada actually have a production technology able to deliver consistent high quality of marijuana: And then as a consequence, none are of course able to utilize the very potent potential of controlled environment production to target and enhance the plants production of specific chemical compounds.
Entering into this 2018 Canadian marijuana industry, the visionary team behind Georgian Bay Biomed recognized the technology opportunity by partnering with Intravision, becoming the first high-end controlled environment cannabis producer, utilizing the full potential of this technology and focusing on a high level of process automation.